Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for AUAAAGU
Z-value: 4.91
Motif logo
miRNA associated with seed AUAAAGU
| Name | miRBASE accession |
|---|---|
|
hsa-miR-142-5p
|
MIMAT0000433 |
|
hsa-miR-5590-3p
|
MIMAT0022300 |
Activity profile of AUAAAGU motif
Sorted Z-values of AUAAAGU motif
Network of associatons between targets according to the STRING database.
First level regulatory network of AUAAAGU
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.0 | 9.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 3.0 | 9.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 2.3 | 6.9 | GO:0060382 | release from viral latency(GO:0019046) regulation of DNA strand elongation(GO:0060382) |
| 1.7 | 6.8 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 1.5 | 4.6 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 1.5 | 6.1 | GO:1903984 | rhythmic synaptic transmission(GO:0060024) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.4 | 5.7 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
| 1.3 | 5.3 | GO:0003186 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) |
| 1.3 | 7.8 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 1.3 | 3.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 1.2 | 4.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 1.0 | 4.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 1.0 | 1.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.8 | 3.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.8 | 5.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.7 | 2.0 | GO:2000797 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.6 | 7.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.6 | 2.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.6 | 13.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.6 | 1.7 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.5 | 1.6 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.5 | 6.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.5 | 1.5 | GO:2000282 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.5 | 5.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.5 | 4.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.5 | 2.3 | GO:0030242 | pexophagy(GO:0030242) |
| 0.5 | 2.3 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) maintenance of chromatin silencing(GO:0006344) |
| 0.5 | 10.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.4 | 6.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.4 | 3.7 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 | 7.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.4 | 1.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.4 | 1.2 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.4 | 1.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.4 | 1.1 | GO:0036233 | glycine import(GO:0036233) |
| 0.4 | 3.0 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.4 | 2.9 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 | 1.0 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.3 | 1.7 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.3 | 6.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.3 | 5.8 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.3 | 5.7 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.3 | 2.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 | 10.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 | 9.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.3 | 1.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.3 | 7.1 | GO:0007567 | parturition(GO:0007567) |
| 0.3 | 11.6 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.3 | 0.5 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.3 | 4.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 1.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.2 | 1.0 | GO:0030047 | actin modification(GO:0030047) |
| 0.2 | 2.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.2 | 1.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.2 | 2.0 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 1.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 | 1.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.2 | 1.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.2 | 0.8 | GO:0060437 | lung growth(GO:0060437) |
| 0.2 | 2.0 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 | 1.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 | 1.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 | 0.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.2 | 6.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.2 | 8.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.2 | 2.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 | 2.8 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.2 | 0.9 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 0.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) uterine wall breakdown(GO:0042704) |
| 0.2 | 2.6 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.2 | 1.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 | 0.7 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) neuron projection maintenance(GO:1990535) |
| 0.2 | 0.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 3.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 | 3.1 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 | 1.8 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.2 | 0.8 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
| 0.2 | 0.5 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 | 0.6 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.2 | 6.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 1.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 12.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 | 5.9 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 | 1.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 8.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 | 2.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.1 | 0.4 | GO:0071315 | late nucleophagy(GO:0044805) cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 | 1.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 8.9 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
| 0.1 | 2.1 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 8.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.1 | 1.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 1.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.1 | 1.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.1 | 0.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.1 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 | 5.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 4.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 | 0.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 3.0 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 1.5 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 0.8 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.1 | 5.7 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
| 0.1 | 0.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 | 14.1 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.1 | 2.0 | GO:0060065 | uterus development(GO:0060065) |
| 0.1 | 2.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 15.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.1 | 1.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 4.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.1 | 0.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.1 | 3.4 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.1 | 1.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.1 | 2.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 | 0.9 | GO:0002190 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 1.8 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.1 | 1.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 1.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.9 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 1.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.0 | 2.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.0 | 3.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 | 1.2 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.0 | 2.9 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.0 | 0.7 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
| 0.0 | 0.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.0 | 0.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 1.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.0 | 2.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.0 | 0.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 | 2.7 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 12.1 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.0 | 4.3 | GO:0046718 | viral entry into host cell(GO:0046718) |
| 0.0 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 | 2.8 | GO:0006024 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 | 3.4 | GO:0035264 | multicellular organism growth(GO:0035264) |
| 0.0 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.9 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.0 | 1.6 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.0 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 | 0.2 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 | 1.4 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.0 | 0.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 1.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 | 0.9 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.0 | 0.5 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.0 | 9.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 1.6 | 4.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 1.0 | 13.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.8 | 2.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.7 | 3.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.7 | 4.4 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.6 | 3.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.6 | 1.8 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.6 | 1.7 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 0.5 | 2.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.5 | 8.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.5 | 4.5 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.5 | 6.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.5 | 1.4 | GO:0000805 | X chromosome(GO:0000805) |
| 0.5 | 9.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.4 | 3.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.4 | 7.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.3 | 7.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.3 | 1.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 0.3 | 5.6 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.3 | 8.1 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.3 | 2.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 3.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.3 | 9.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.2 | 2.0 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.2 | 1.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.2 | 0.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.2 | 2.9 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 2.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 3.2 | GO:0032059 | bleb(GO:0032059) |
| 0.2 | 2.1 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.2 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.2 | 1.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.2 | 1.8 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.2 | 1.9 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.2 | 10.7 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.2 | 1.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 0.7 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.1 | 0.4 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.1 | 0.9 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 1.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 1.4 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 1.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 11.9 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.1 | 1.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 3.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 4.3 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 8.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 2.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 6.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 2.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 1.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.1 | 5.3 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 1.3 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.1 | 2.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 6.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 2.2 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.1 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 1.5 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 0.4 | GO:0070449 | elongin complex(GO:0070449) |
| 0.0 | 3.4 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.0 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
| 0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 6.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 3.5 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 1.4 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 4.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 20.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 1.4 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 1.5 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 5.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 1.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 3.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 0.2 | GO:1990752 | microtubule end(GO:1990752) |
| 0.0 | 2.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 6.1 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
| 1.4 | 13.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 1.3 | 13.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 1.2 | 3.7 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 1.2 | 10.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 1.1 | 9.0 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 1.0 | 6.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.9 | 7.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.7 | 5.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.7 | 7.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.7 | 4.6 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.6 | 3.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.6 | 6.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.5 | 6.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.5 | 1.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.5 | 1.5 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.5 | 6.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.5 | 4.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.5 | 5.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.4 | 2.6 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.4 | 1.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.4 | 6.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 1.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.3 | 1.7 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.3 | 1.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.3 | 0.9 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.3 | 1.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.3 | 13.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.3 | 9.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.3 | 2.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 1.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.3 | 0.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.3 | 8.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 2.0 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.2 | 3.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.2 | 1.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 5.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.2 | 3.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.2 | 3.0 | GO:0031386 | protein tag(GO:0031386) |
| 0.2 | 2.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
| 0.2 | 1.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.2 | 8.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 6.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 3.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 3.0 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.2 | 1.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.2 | 1.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.2 | 7.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.2 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.1 | 1.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 1.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 12.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 0.7 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.1 | 6.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 5.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 4.5 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.1 | 4.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 1.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.1 | 17.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.1 | 4.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 8.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 3.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 3.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 6.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 3.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 1.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 3.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 2.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.1 | 6.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.1 | 3.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 1.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 1.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 0.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 0.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 1.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) triglyceride lipase activity(GO:0004806) |
| 0.1 | 1.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 2.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.1 | 2.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 1.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 1.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.0 | 0.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.0 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 8.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 1.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.0 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.0 | 6.2 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
| 0.0 | 1.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 2.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
| 0.0 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 8.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 2.5 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 1.6 | GO:0008026 | ATP-dependent RNA helicase activity(GO:0004004) ATP-dependent helicase activity(GO:0008026) RNA-dependent ATPase activity(GO:0008186) purine NTP-dependent helicase activity(GO:0070035) |
| 0.0 | 1.3 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 1.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 3.0 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 1.9 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.0 | 3.7 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 2.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.0 | 0.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.0 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.0 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.0 | 6.2 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 1.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 1.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.0 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.0 | 0.0 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 4.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.3 | 6.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.3 | 15.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.2 | 12.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.2 | 12.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 7.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 9.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 2.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 1.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 2.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 4.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 2.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 7.7 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 12.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 1.8 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 1.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 4.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 8.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 2.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.5 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 2.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 2.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 2.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 0.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 3.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.0 | 0.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 9.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.5 | 6.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.3 | 12.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.3 | 10.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.3 | 5.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.3 | 6.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.3 | 4.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.2 | 9.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 3.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.2 | 9.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 7.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 4.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 1.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.1 | 2.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 3.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 5.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 4.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 6.5 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 13.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 10.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 4.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 1.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 2.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 1.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 1.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 2.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.0 | 1.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 2.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 5.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.8 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.0 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.0 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 0.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 2.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 1.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 1.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.0 | 1.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |